Patents Assigned to BioNTech Disgnostics GmbH
  • Methods and kits for the diagnosis of cancer
    Patent number: 10705089
    Abstract: The present invention relates to methods and kits for the diagnosis, prognosis and/or monitoring of cancer in a patient. The present invention further relates to isolated peptides, panels of isolated peptides and diagnostic devices.
    Type: Grant
    Filed: April 15, 2015
    Date of Patent: July 7, 2020
    Assignees: BioNTech Disgnostics GmbH, TRON-Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH
    Inventors: Rainer Hipfel, Clara Werner, Andree Rothermel, Ugur Sahin, Yvonne Kuhne